Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Capricor Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 34 | 37 | +3 |
| Shares | 5.54M | 4.02M | −1.52M (−27.4%) |
| Value | $18.9M | $19.7M | +$718.6K (+3.8%) |
New holders (6)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 909,542 | $4.45M | 0.05% |
| Jump Financial, LLC | 52,800 | $258.2K | 0.01% |
| Jane Street Group, LLC | 40,039 | $195.8K | 0.00% |
| Two Sigma Investments, LP | 19,700 | $96.3K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 10,263 | $50.2K | 0.00% |
| McGlone Suttner Wealth Management, Inc. | 423 | $2.07K | 0.00% |
Sold out (3)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Highbridge Capital Management LLC | 2,789,699 | $9.54M |
| Citadel Advisors LLC | 20,861 | $71.3K |
| Cutler Group LP | 1,000 | $3.00K |